COVID-19: all 7,776 studies

Page 32 of 78. Open to participants first (483), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and AdolescentsTerminatedNCT05169008Phase 3
• COVID-19, Patients' Evolution and the Influence of the Pandemic on Health Care and Outcomes in Chronic DiseasesCompletedNCT05168722
• Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection ReductionCompletedNCT05168709Phase 4
• Coronaltitude - Multicentric Evaluation of the Impact on Hypoxia Sensitivity of Patients With COVID-19CompletedNCT05167357Not applicable
• A Study of JS026 and JS026 Together With JS016 for Treatment of COVID-19CompletedNCT05167279Phase 1
• A Study to Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines.WithdrawnNCT05167253Phase 1
• ESH ABPM COVID-19 STUDYStatus unknownNCT05167240
• Respiratory COVID-19: A Randomized, Sham-Controlled StudyWithdrawnNCT05166915Not applicable
• Severity of COVID-19 and Vitamin D SupplementationStatus unknownNCT05166005Phase 4
• Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19Status unknownNCT05165992Phase 3
• Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in BrazilActive, not recruitingNCT05165979
• Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19CompletedNCT05165966Phase 4
• Relationship Between Bronchial Asthma and COVID-19 Infection in Adults: Clinical and Laboratory AssessmentCompletedNCT05165953
• Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19SuspendedNCT05165732Phase 4
• Validation of 'Corona-T-test' for Assessment of SARS-COV-2-specific T-cell Response After COVID-19 or VaccinationCompletedNCT05165719
• Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and AboveStatus unknownNCT05164731Phase 3
• A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19CompletedNCT05164133Phase 1
• Diet and COVID-19 VaccinationStatus unknownNCT05163743Not applicable
• Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid PanelCompletedNCT05163730Not applicable
• Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and AboveStatus unknownNCT05163652Phase 3
• Use of Low-frequency Magnetic Fields in the Hybrid Treatment of COVID-19 PatientsStatus unknownNCT05163613Not applicable
• Independent Predictors on Clinical Outcomes in SARS-CoV2 PatientsCompletedNCT05162534
• Combination Assessment Trial of COVID-19 Vaccines (COMBAT-COVID)Status unknownNCT05162482Phase 2
• Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ TransplantationStatus unknownNCT05162456
• A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19TerminatedNCT05162365Phase 1/2
• CovidSurg-3: Outcomes of Surgery in COVID-19 InfectionStatus unknownNCT05161299
• Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients With COVID19Status unknownNCT05160779Not applicable
• Effect of Covid 19 Infection on Fetomaternal OutcomeStatus unknownNCT05160649
• A Study to Look at the Health Outcomes of Patients With COVID-19 and InfluenzaActive, not recruitingNCT05160636
• Post Covid-19 Vaccination Development or Flare of ARDStatus unknownNCT05160428
• Effect of Post Covid-19 Hypoxia on Placenta of Normal Pregnant Women: A Possible Role of Hypoxia Inducible Factor-1α.Status unknownNCT05158868
• Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 VaccineCompletedNCT05158855Not applicable
• Treatment of COVID-19 Positive/Negative Bangladeshi Adults With Severe Respiratory Complaints by a Locally Made bCPAP: Feasibility StudyCompletedNCT05158842Not applicable
• Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19CompletedNCT05158816
• Lung Ultrasound in Comparison With C.T in Covid-19Status unknownNCT05158803
• Impact of Covid-19 on Training for ENT and Cervico-Facial Surgery Residents in FranceStatus unknownNCT05158790
• Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody CocktailWithdrawnNCT05157997Phase 1
• Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe IllnessWithdrawnNCT05157269Phase 3
• Monitoring of Anti-SARS-CoV-2 (COVID 19) and Encapsulated Vaccination Patients With Thalassemic and Falcemic SyndromesActive, not recruitingNCT05157256
• Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe IllnessWithdrawnNCT05157243Phase 3
• Impact of the Genetic Polymorphism on COVID-19 in EgyptStatus unknownNCT05157217
• Measurment of Interleuukin-6 at Exhaled Breath Condensate of Covid-19 Patients and Post Covid-19 Patients With Lung Fibrosis Randomized Controlled StudyStatus unknownNCT05157204
• Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.Active, not recruitingNCT05157178Phase 4
• Convalescent Plasma in Hospitalized COVID-19 PatientsNo longer availableNCT05157165
• Elevated Liver Enzymes as a Predictor of Acute Kidney Injury in Hospitalized Patients With COVID-19Status unknownNCT05157152
• Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral DiseaseStatus unknownNCT05157139Phase 2/3
• Testing a Mindfulness/Acceptance-Based Smartphone App for Nurses Impacted by the COVID-19 PandemicStatus unknownNCT05157035Early Phase 1
• Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.CompletedNCT05156723Phase 1/2
• Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 TrialTerminatedNCT05156671Phase 2
• A Study to Evaluate Efficacy and Safety of the Combination of SCTA01 & SCTA01C in Outpatients With COVID-19WithdrawnNCT05156645Phase 1/2
• Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and AboveWithdrawnNCT05156632Phase 3
• 'Long COVID-19' in Suffolk and North Essex: Defining the Disease and Optimising OutcomesCompletedNCT05156593
• Safety and Effectiveness of COVID-19 Vaccine in Kidney Transplant RecipientsStatus unknownNCT05156086
• Ivermectin With Favipiravir in Mild-to-moderate COVID-19 PatientsStatus unknownNCT05155527Phase 2
• Implementing Virtual Parent Support Groups for Eating Disorders Across CanadaCompletedNCT05151900Not applicable
• Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 InfectionCompletedNCT05151614Phase 1
• The Validity of the ROX Index in Predicting Intubation in Patients With Covid-19 PneumoniaCompletedNCT05150886
• Prone Positioning in COVID-19 PatientsStatus unknownNCT05150847Not applicable
• Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 VaccinesStatus unknownNCT05150834
• Impact of Covid-19 in the Emergency DepartmentCompletedNCT05150821
• The Effect of Micellized Food Supplements on Health-related Quality of Life in Patients With Post-acute COVID-19 Syndrome.Status unknownNCT05150782Not applicable
• The Diagnosis of Superinfections in Mechanically Ventilated Covid-19 PatientsStatus unknownNCT05148975
• Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis PatientsStatus unknownNCT05148949Phase 4
• Communities Fighting COVID-19!CompletedNCT05148936Not applicable
• Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 VaccineActive, not recruitingNCT05148871Phase 2/3
• Sleep Quality and Quality of Life in Coronavirus 19 Disease ( COVID 19) PatientsStatus unknownNCT05148858
• Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.CompletedNCT05148845Phase 3
• Administration of Systemic Corticosteroids and the Recovery of Gustatory Functions in Patients With COVID-19CompletedNCT05148832Not applicable
• Assessment of Sexual Dysfunction Among COVID-19 Recovered PatientsStatus unknownNCT05148819
• Residual Symptoms and the Quality of Life in Individuals Recovered From COVID-19 Infection: A Survey From PakistanCompletedNCT05148676
• The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated AdultsCompletedNCT05148091Phase 1/2
• Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant SettingStatus unknownNCT05145803
• SARS CoV-2 Infection and Inflammatory BiomarkersCompletedNCT05145751
• Insight Into the UAE Experience With Monoclonal Antibodies (Sotrovimab )Status unknownNCT05144178
• A Phase I/II Clinical Trial in Healthy People Aged 18 Years and AboveCompletedNCT05144139Phase 1/2
• 3D Printed Mask Adapter Designed From Facial 3D Scans for Fit Testing.WithdrawnNCT05143814
• Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic ComplicationsCompletedNCT05143567Not applicable
• Influence of Vibroacoustic Therapy Modes on the Course of Coronavirus InfectionCompletedNCT05143372Not applicable
• Cognitive Assessment in COVID-19 Positive Patients Using the DANA AppCompletedNCT05143333
• Cognitive, Emotional and Behavioural Impairments in Patients After Sars-Cov2 InfectionCompletedNCT05143320
• Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.CompletedNCT05142553Phase 2
• Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19WithdrawnNCT05142527Phase 2/3
• Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)CompletedNCT05142514Phase 2
• Observation of the Immune Response After COVID-19 Additional Vaccine Doses in Chronic Patients in Hemodialysis TherapyTerminatedNCT05142501
• Study of Immunogenicity Equivalence of a Homologous Third Dose of Covid-19 (Recombinante) VaccineStatus unknownNCT05142488Phase 4
• Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]CompletedNCT05142319Phase 4
• GlowTest COVID-19 Antigen Home Test Kit QRI Use StudyCompletedNCT05140005Not applicable
• Yogic Breathing and Guided Meditation for Long Covid SymptomsCompletedNCT05139979Not applicable
• Impact of COVID-19 Infection During PregnancyCompletedNCT05139953
• Usefulness of DORNASE in COVID-19 on HFNOTerminatedNCT05139901Phase 4
• Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Conditions.Status unknownNCT05138666Not applicable
• A Study of the Infection and Transmission of SARS-CoV-2 in Paediatric PatientsStatus unknownNCT05137535
• High-flow Nasal Oxygenation and Non-invasive Ventilation Strategies for the Treatment of Covid-19 PneumoniaCompletedNCT05137431
• Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 YearsCompletedNCT05137418Phase 3
• The Glycocalyx in COVID-19 Patients. A Pilot StudyCompletedNCT05137249
• SP16 as a Therapeutic for COVID-19 Induced ARDSTerminatedNCT05135624Phase 1
• Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF TrialTerminatedNCT05135546Phase 2/3
• VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Long-term Safety of VAXZEVRIACompletedNCT05135455
• Anesthesia Technique in COVID-19 Positive Hip Fracture PatientsStatus unknownNCT05133648
• High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19WithdrawnNCT05133635Phase 4

← COVID-19 overview